Literature DB >> 3277523

Cholesteatoma in the pediatric age group.

D R Edelstein1, S C Parisier, G S Ahuja, C Juarbe, P Chute, S Wenig, S M Kaye.   

Abstract

The diagnosis and management of cholesteatoma in children remains controversial. In the past 15 years, the senior author (S.C.P.) has treated 320 patients with cholesteatoma. Patients 18 years and younger composed 40% (125) of the overall group and are the basis for this report. The patient data were compiled using the history, physical examination, audiograms, radiographs, patient questionnaires, surgical findings, and postoperative observations. The surgical treatment selected was determined by the extent of disease, the configuration of the mastoid, and a clinical assessment of eustachian tube function. A middle ear tympanotomy approach was used in 17% of the patients, a canal wall up procedure in 31%, and a canal wall down procedure in 52.3%. The average clinical follow-up was 3.9 years, with the range being from 3 months to 13.5 years. Hearing was maintained or slightly improved in a majority of cases. Residual disease occurred in 8% of patients, and recurrent disease in only 3%.

Entities:  

Mesh:

Year:  1988        PMID: 3277523     DOI: 10.1177/000348948809700105

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  3 in total

1.  Aggressiveness of pediatric cholesteatoma. Do we have an evidence?

Authors:  Zareen A Lynrah; Jaimanti Bakshi; Naresh K Panda; N K Khandelwal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-08-22

2.  Modified Radical Mastoidectomy with Type III Tympanoplasty: Revisited.

Authors:  Rashmi Goyal; Ashish Mourya; Sadat Qureshi; Sandeep Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-08-22

Review 3.  Some considerations about acquired adult and pediatric cholesteatomas.

Authors:  Cristina Dornelles; Sady S da Costa; Luíse Meurer; Cláudia Schweiger
Journal:  Braz J Otorhinolaryngol       Date:  2005-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.